Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
$25.00
Provider: Pechala's Reports
$25.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Kindred Biosciences Inc announces pricing of IPO


Wednesday, 11 Dec 2013 10:44pm EST 

Kindred Biosciences Inc:Says pricing of its initial public offering of 7,500,000 shares of its common stock at an initial public offering price of $7.00 per share for a total offering amount of $52,500,000 before deducting underwriting discounts and commissions and estimated offering expenses payable by Kindred Bio.Says it has granted to the underwriters a 30-day option to purchase an additional 1,125,000 shares of its common stock at the initial public offering price.Says all of the shares are being offered by Kindred Bio.Says the shares are expected to begin trading under the ticker 'KIN' on the NASDAQ Capital Market on Dec.12.Says BMO Capital Markets and Guggenheim Securities are acting as book-running managers for the offering and Roth Capital Partners is acting as co-manager for the offering. 

Company Quote

6.88
0.1 +1.47%
19 Dec 2014